Sampayan, Rochelle D.

HRN: 21-80-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2022
CEFUROXIME 500MG (TAB)
09/08/2022
09/15/2022
ORAL
1 Cap
BID
SP LTCS
Waiting Final Action 
09/08/2022
CEFUROXIME 1.5GM (VIAL)
09/08/2022
09/10/2022
IV
1.5g Then 750
Q8 Hrs
SP LTCS

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: